<DOC>
	<DOCNO>NCT00547898</DOCNO>
	<brief_summary>This randomize , double-blind , parallel-group , placebo-controlled , multi-center study . This study compare investigational new drug ( crofelemer ) placebo control HIV-associated diarrhea . The first stage study determine optimal dose study drug base safety response therapy second stage evaluate effectiveness optimal dose .</brief_summary>
	<brief_title>Safety Effectiveness 3 Doses Crofelemer Compared Placebo Treatment HIV Associated Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<criteria>History HIV1 infection confirm standard serological test Stable medical regimen treatment HIV disease associate condition least 4 week prior screen Patientreported history diarrhea , define either persistently loose stool despite regular ADM use , one watery bowel movement per day without regular ADM use , least 1 month duration Colonoscopy within past 5 year â‰¥ 50 year age . Pregnancy breastfeed Current past gastrointestinal ( GI ) medical surgical condition Use certain opiate pain medication within 2 week screen Use antibiotic within 2 week prior screen , exception stable antibiotic therapy prophylactic treatment infection HIVassociated condition CD4 count &lt; 100 cells/mm3 Previous randomization study , crofelemer study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>HIV Associated Diarrhea</keyword>
</DOC>